Sign inJoin waitlistJoin the waitlist

Amelia Zelnak

Physician · Northside Hospital

Credentials: · · ·

History

Northside Hospital
Present

Medical Oncology
2004–2006
Internal Medicine
2001–2004
Emory University School of Medicine
1997–2001

Research

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
New England Journal of Medicine · 2021 · 1,378 citations
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial
Journal of Clinical Oncology · 2020 · 452 citations
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
Annals of Oncology · 2021 · 280 citations

Ruth O’Regan
18 papers
Mylin Torres
6 papers
EP
Elisavet Paplomata
5 papers · 1 as a fellow
Lisa Carey
5 papers
Sara Hurvitz
5 papers
EH
Erika Hamilton
4 papers
Monica Rizzo
4 papers
SG
Sheryl Gabram
4 papers
Aditya Bardia
3 papers
Carolina Fasola
3 papers · 3 as a resident
Hope Rugo
3 papers
Jo Chien
3 papers

Clinical trials

A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer
Principal investigator · Terminated · Phase 2
Emory University
2008–2009
Randomized Phase II Trial Induction Therapy for Early Stage Breast Cancer
Principal investigator · Completed · Phase 2
Emory University
2006–2012
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Site PI · Recruiting · Phase 3
Stemline Therapeutics, Inc.
2024–2032
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034